In contrast, longitudinal studies of patients with multiple sclerosis, traumatic brain injury, and stroke have shown that after increasing over days sNfL levels can remain elevated over months [32], which appears consistent with the associations of higher sNfL with shorter time to first manifestation of disease and shorter time to last attack in patients with AQP4-IgG+ NMOSD and MOG-IgG+ patients observed in the present work (Table 3). This evidence concerns the gene MOG and multiple sclerosis.